• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

Introduction to 2,2,6-trimethylmorpholine (CAS No. 113889-14-8): Applications and Recent Research Developments

2,2,6-trimethylmorpholine, identified by the Chemical Abstracts Service Number (CAS No.) 113889-14-8, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceuticals and materials science due to its unique chemical properties. This compound belongs to the morpholine family, characterized by a six-membered ring containing an oxygen atom and two alkyl groups. The specific arrangement of methyl groups in 2,2,6-trimethylmorpholine contributes to its distinctive physicochemical characteristics, making it a versatile intermediate in synthetic chemistry and a potential candidate for various industrial applications.

The structural configuration of 2,2,6-trimethylmorpholine imparts stability and reactivity that are exploited in multiple domains. Its molecular structure allows for interactions with other molecules, which is particularly relevant in drug design and development. The compound’s ability to form stable complexes with metal ions has been explored in catalysis and as a ligand in coordination chemistry. This property has opened avenues for research in developing novel catalysts for organic transformations, which are essential in pharmaceutical synthesis.

In recent years, 2,2,6-trimethylmorpholine has been studied for its potential applications in polymer chemistry. Its incorporation into polymer matrices enhances thermal stability and mechanical strength, making it valuable in the production of high-performance materials. These materials find applications in automotive components, electronics, and aerospace industries where durability and heat resistance are critical.

One of the most promising areas of research involving 2,2,6-trimethylmorpholine is its role as a solvent or co-solvent in pharmaceutical formulations. Traditional solvents used in drug formulation often pose environmental and health concerns. 2,2,6-trimethylmorpholine, with its low toxicity profile and high solvency power for a wide range of compounds, presents an eco-friendly alternative. Recent studies have demonstrated its effectiveness in enhancing the solubility of poorly soluble drugs, thereby improving bioavailability and therapeutic efficacy.

The pharmaceutical industry has also explored 2,2,6-trimethylmorpholine as a building block for synthesizing biologically active molecules. Its morpholine core is a common motif in many pharmacologically active compounds due to its ability to mimic biological structures and interact with biological targets. Researchers have reported the use of 2,2,6-trimethylmorpholine derivatives as intermediates in the synthesis of antiviral and anti-inflammatory agents. These derivatives exhibit promising activities by modulating enzymatic pathways involved in disease progression.

Another emerging application of 2,2,6-trimethylmorpholine is in the field of energy storage devices. Its ability to stabilize lithium metal anodes has been investigated extensively. By forming a protective layer on the surface of lithium metal during charging cycles, 2,2,6-trimethylmorpholine helps prevent dendrite formation and enhances the cycle life of lithium-ion batteries. This research is crucial for developing next-generation energy storage solutions that are more efficient and safer.

The chemical stability of 2,2,6-trimethylmorpholine under various conditions has also been a focus of recent studies. Researchers have examined its behavior under extreme temperatures and pressures to assess its suitability for industrial processes that require harsh conditions. The findings suggest that 2,2,6-trimethylmorpholine can withstand such conditions without significant degradation, making it a reliable component in high-performance chemical systems.

In conclusion, 113889-14-8 derived from CAS No., CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No.,CAS No., CAS No.. It continues to be an area of active investigation with potential implications across multiple scientific disciplines. As research progresses, 113889-14-8 derived from CAS No, will likely find even broader applications due to its unique properties and versatility.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)